References
1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features,
evaluation and treatment coronavirus (COVID-19). Statpearls
[internet]: StatPearls Publishing; 2020.
2. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019
(COVID-19): current status and future perspectives. Int J Antimicrob
Agents. 2020:105951-.
3. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E.
COVID-19, SARS and MERS: are they closely related? Clinical microbiology
and infection : the official publication of the European Society of
Clinical Microbiology and Infectious Diseases. 2020.
4. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian
journal of pediatrics. 2020;87(4):281-6.
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The
Lancet. 2020;395(10223):497-506.
6. Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi D, Veraldi S, et al.
Cutaneous manifestations of COVID-19: Report of three cases and a review
of literature. J Dermatol Sci. 2020:S0923-1811(20)30149-3.
7. WHO. Coronavirus disease 2019 (COVID-19) Situation Report - 114 2020
[Available from:
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200513-covid-19-sitrep-114.pdf?sfvrsn=17ebbbe_4.
8. Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S. Therapeutic
opportunities to manage COVID-19/SARS-CoV-2 infection: Present and
future. Indian journal of ophthalmology. 2020;68(5):693.
9. ClinicalTrials.gov. A Study of Hydroxychloroquine, Vitamin C, Vitamin
D, and Zinc for the Prevention of COVID-19 Infection:
https://ClinicalTrials.gov/show/NCT04335084; 2020 [
10. Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A,
Allegrini P, et al. Self-Care for Common Colds: The Pivotal Role of
Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune
Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity)
Involved during an Episode of Common Colds-Practical Advice on Dosages
and on the Time to Take These Nutrients/Botanicals in order to Prevent
or Treat Common Colds. Evid Based Complement Alternat Med.
2018;2018:5813095-.
11. Shah D, Gupta P. Vitamin D Deficiency: Is The Pandemic for Real?
Indian J Community Med. 2015;40(4):215-7.
12. Holick MF. The vitamin D deficiency pandemic: Approaches for
diagnosis, treatment and prevention. Reviews in endocrine & metabolic
disorders. 2017;18(2):153-65.
13. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, et al. Vitamin D and
Chronic Diseases. Aging Dis. 2017;8(3):346-53.
14. Holick MF. Vitamin D: importance in the prevention of cancers, type
1 diabetes, heart disease, and osteoporosis. The American journal of
clinical nutrition. 2004;79(3):362-71.
15. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical
applications. Chem Biol. 2014;21(3):319-29.
16. Morris HA, Anderson PH. Autocrine and paracrine actions of vitamin
d. Clin Biochem Rev. 2010;31(4):129-38.
17. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune
function. Nutrients. 2013;5(7):2502-21.
18. Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective
for health. Dermatoendocrinol. 2013;5(1):51-108.
19. Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D. Impact of
oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in
oncology. Nutrition Journal. 2010;9(1):60.
20. Gowda U, Ruwanpathirana T, Fong DPS, Kaur A, Renzaho AMN. Efficacy
of high dose Vitamin D supplementation in improving serum 25(OH)D among
migrant and non migrant population: a retrospective study. BMC Health
Services Research. 2016;16(1):579.
21. Zhang R, Naughton DP. Vitamin D in health and disease: current
perspectives. Nutrition journal. 2010;9:65-.
22. Nair R, Maseeh A. Vitamin D: The ”sunshine” vitamin. J Pharmacol
Pharmacother. 2012;3(2):118-26.
23. Hewison M. Antibacterial effects of vitamin D. Nature Reviews
Endocrinology. 2011;7(6):337.
24. Khoo AL, Chai L, Koenen H, Joosten I, Netea M, van der Ven A.
Translating the role of vitamin D3 in infectious diseases. Critical
reviews in microbiology. 2012;38(2):122-35.
25. Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the
infection connection. Inflammation Research. 2014;63(10):803-19.
26. White JH. Vitamin D metabolism and signaling in the immune system.
Reviews in endocrine and metabolic disorders. 2012;13(1):21-9.
27. Nouari W, Ysmail-Dahlouk L, Aribi M. Vitamin D3 enhances
bactericidal activity of macrophage against Pseudomonas aeruginosa.
International immunopharmacology. 2016;30:94-101.
28. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state.
J Clin Virol. 2011;50(3):194-200.
29. Zasloff M. Fighting infections with vitamin D. Nature medicine.
2006;12(4):388-90.
30. Turner J, Cho Y, Dinh N-N, Waring AJ, Lehrer RI. Activities of
LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
Antimicrobial agents and chemotherapy. 1998;42(9):2206-14.
31. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, Keller MJ, et al. Human
α- and β-Defensins Block Multiple Steps in Herpes Simplex Virus
Infection. The Journal of Immunology. 2006;177(12):8658-66.
32. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, et al. θ
Defensins Protect Cells from Infection by Herpes Simplex Virus by
Inhibiting Viral Adhesion and Entry. Journal of Virology.
2004;78(10):5147-56.
33. Tripathi S, Tecle T, Verma A, Crouch E, White M, Hartshorn KL. The
human cathelicidin LL-37 inhibits influenza A viruses through a
mechanism distinct from that of surfactant protein D or defensins. J Gen
Virol. 2013;94(Pt 1):40-9.
34. Aranow C. Vitamin D and the immune system. J Investig Med.
2011;59(6):881-6.
35. Gil A, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions.
Annals of Nutrition and Metabolism. 2018;72(2):87-95.
36. Szymczak I, Pawliczak R. The Active Metabolite of Vitamin D3 as a
Potential Immunomodulator. Scandinavian Journal of Immunology.
2016;83(2):83-91.
37. Zheng S, Yang J, Hu X, Li M, Wang Q, Dancer RCA, et al. Vitamin D
attenuates lung injury via stimulating epithelial repair, reducing
epithelial cell apoptosis and inhibits TGF-β induced epithelial to
mesenchymal transition. Biochemical Pharmacology. 2020:113955.
38. Dancer RCA, Parekh D, Lax S, D’Souza V, Zheng S, Bassford CR, et al.
Vitamin D deficiency contributes directly to the acute respiratory
distress syndrome (ARDS). Thorax. 2015;70(7):617-24.
39. Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates
lipopolysaccharide‑induced acute lung injury via regulation of the
renin‑angiotensin system. Molecular medicine reports. 2017;16(5):7432-8.
40. Hileman CO, Overton ET, McComsey GA. Vitamin D and bone loss in HIV.
Current Opinion in HIV and AIDS. 2016;11(3):277.
41. Alvarez N, Aguilar-Jimenez W, Rugeles MT. The Potential Protective
Role of Vitamin D Supplementation on HIV-1 Infection. Front Immunol.
2019;10(2291).
42. Lake JE, Adams JS. Vitamin D in HIV-Infected Patients. Curr HIV/AIDS
Rep. 2011;8(3):133-41.
43. Okoye AA, Picker LJ. CD 4+ T‐cell depletion in HIV infection:
mechanisms of immunological failure. Immunological reviews.
2013;254(1):54-64.
44. Abraham AG, Zhang L, Calkins K, Tin A, Hoofnagle A, Palella FJ, Jr.,
et al. Vitamin D status and immune function reconstitution in
HIV-infected men initiating therapy. AIDS (London, England).
2018;32(8):1069-76.
45. Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A,
Resino S. Vitamin D in human immunodeficiency virus infection: influence
on immunity and disease. Front Immunol. 2018;9:458.
46. Mansueto P, Seidita A, Vitale G, Gangemi S, Iaria C, Cascio A.
Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed
Res Int. 2015;2015:735615-.
47. Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A,
Resino S. Vitamin D in Human Immunodeficiency Virus Infection: Influence
on Immunity and Disease. Front Immunol. 2018;9:458-.
48. Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, et
al. Vitamin D3 supplementation in HIV infection: effectiveness and
associations with antiretroviral therapy. Nutrition Journal.
2015;14(1):81.
49. Connor RI, Rigby WF. 1 alpha,25-dihydroxyvitamin D3 inhibits
productive infection of human monocytes by HIV-1. Biochemical and
biophysical research communications. 1991;176(2):852-9.
50. Schuitemaker H, Kootstra NA, Koppelman MH, Bruisten SM, Huisman HG,
Tersmette M, et al. Proliferation-dependent HIV-1 infection of monocytes
occurs during differentiation into macrophages. The Journal of clinical
investigation. 1992;89(4):1154-60.
51. Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M.
Association between vitamin D and hepatitis C virus infection: a
meta-analysis. World journal of gastroenterology. 2013;19(35):5917-24.
52. Gutierrez JA, Jones KA, Flores R, Singhania A, Woelk CH, Schooley
RT, et al. Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate
Cellular Gene Expression. J Virol Antivir Res.
2014;3(3):10.4172/2324-8955.1000129.
53. Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan
shield and structure prediction of spike glycoprotein and its
interaction with human CD26. Emerging microbes & infections.
2020;9(1):601-4.
54. McCartney D, Byrne D. Optimisation of Vitamin D Status for Enhanced
Immuno-protection Against Covid-19.
55. Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K,
Chattrasophon K, Thaimai P, et al. Vitamin D supplementation improves
serum markers associated with hepatic fibrogenesis in chronic hepatitis
C patients: A randomized, double-blind, placebo-controlled study.
Scientific Reports. 2017;7(1):8905.
56. Hewings-Martin Y. How do SARS and MERS compare with COVID-19?
[Newsletter]. MEDICALNEWSTODAY; 2020 [updated 10 April 2020.
Available from:
https://www.medicalnewstoday.com/articles/how-do-sars-and-mers-compare-with-covid-19.
57. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A
review. Clin Immunol. 2020:108427.
58. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman
P, et al. Vitamin D supplementation to prevent acute respiratory tract
infections: systematic review and meta-analysis of individual
participant data. BMJ. 2017;356:i6583.
59. Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, et
al. Rates and risk factors associated with hospitalization for pneumonia
with ICU admission among adults. BMC Pulm Med. 2017;17(1):208-.
60. Marston BJ, Plouffe JF, File TM, Jr., Hackman BA, Salstrom SJ,
Lipman HB, et al. Incidence of community-acquired pneumonia requiring
hospitalization. Results of a population-based active surveillance Study
in Ohio. The Community-Based Pneumonia Incidence Study Group. Archives
of internal medicine. 1997;157(15):1709-18.
61. Jat KR. Vitamin D deficiency and lower respiratory tract infections
in children: a systematic review and meta-analysis of observational
studies. Tropical doctor. 2017;47(1):77-84.
62. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a
linear association with seasonal infections and lung function in British
adults. The British journal of nutrition. 2011;106(9):1433-40.
63. Ginde AA, Mansbach JM, Camargo CA, Jr. Association between serum
25-hydroxyvitamin D level and upper respiratory tract infection in the
Third National Health and Nutrition Examination Survey. Archives of
internal medicine. 2009;169(4):384-90.
64. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry
ML. Serum 25-hydroxyvitamin d and the incidence of acute viral
respiratory tract infections in healthy adults. PLoS One.
2010;5(6):e11088.
65. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki
H, et al. An association of serum vitamin D concentrations <
40 nmol/L with acute respiratory tract infection in young Finnish men.
Am J Clin Nutr. 2007;86(3):714-7.
66. Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M,
Chandramohan D, et al. Effects of vitamin D supplementation to children
diagnosed with pneumonia in Kabul: a randomised controlled trial.
Tropical medicine & international health : TM & IH.
2010;15(10):1148-55.
67. Camargo CA, Jr., Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ,
Kleinman K, et al. Randomized trial of vitamin D supplementation and
risk of acute respiratory infection in Mongolia. Pediatrics.
2012;130(3):e561-7.
68. Choudhary N, Gupta P. Vitamin D supplementation for severe
pneumonia–a randomized controlled trial. Indian pediatrics.
2012;49(6):449-54.
69. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta
ZA, et al. Effect on the incidence of pneumonia of vitamin D
supplementation by quarterly bolus dose to infants in Kabul: a
randomised controlled superiority trial. Lancet (London, England).
2012;379(9824):1419-27.
70. Das RR, Singh M, Panigrahi I, Naik SS. Vitamin D supplementation for
the treatment of acute childhood pneumonia: a systematic review. ISRN
pediatrics. 2013;2013.
71. Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway
infections: a European perspective. European journal of medical
research. 2016;21(1):14.
72. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H.
Randomized trial of vitamin D supplementation to prevent seasonal
influenza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255-60.
73. Kearns MD, Alvarez JA, Seidel N, Tangpricha V. Impact of vitamin D
on infectious disease. Am J Med Sci. 2015;349(3):245-62.
74. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et
al. Epidemic influenza and vitamin D. Epidemiology and infection.
2006;134(6):1129-40.
75. Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of
subclinical vitamin D deficiency in newborns with acute lower
respiratory infection and their mothers. European journal of clinical
nutrition. 2009;63(4):473-7.
76. Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute
lower respiratory infection in early childhood in Sylhet, Bangladesh.
Acta paediatrica (Oslo, Norway : 1992). 2010;99(3):389-93.
77. Hurwitz JL, Jones BG, Penkert RR, Gansebom S, Sun Y, Tang L, et al.
Low Retinol-Binding Protein and Vitamin D Levels Are Associated with
Severe Outcomes in Children Hospitalized with Lower Respiratory Tract
Infection and Respiratory Syncytial Virus or Human Metapneumovirus
Detection. J Pediatr. 2017;187:323-7.
78. Walker VP, Modlin RL. The vitamin D connection to pediatric
infections and immune function. Pediatr Res. 2009;65(5 Pt 2):106R-13R.
79. Halasa N, Williams J, Faouri S, Shehabi A, Vermund SH, Wang L, et
al. Natural history and epidemiology of respiratory syncytial virus
infection in the Middle East: Hospital surveillance for children under
age two in Jordan. Vaccine. 2015;33(47):6479-87.
80. Quraishi SA, Bittner EA, Christopher KB, Camargo Jr CA. Vitamin D
status and community-acquired pneumonia: results from the third National
Health and Nutrition Examination Survey. PLoS One. 2013;8(11).
81. Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, et
al. Vitamin D deficiency in community-acquired pneumonia: low levels of
1,25(OH)2 D are associated with disease severity. Respiratory Research.
2014;15(1):53.
82. Perez MO, Oliveira RM, Levy-Neto M, Caparbo VF, Pereira RMR. Serum
25-hydroxyvitamin D levels in patients with Granulomatosis with
Polyangiitis: association with respiratory infection. Clinics (Sao
Paulo). 2017;72(12):723-8.
83. Hansdottir S, Monick MM. Chapter Nine - Vitamin D Effects on Lung
Immunity and Respiratory Diseases. In: Litwack G, editor. Vitamins &
Hormones. 86: Academic Press; 2011. p. 217-37.
84. Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V.
The Possible Role of Vitamin D in Suppressing Cytokine Storm and
Associated Mortality in COVID-19 Patients. medRxiv.
2020:2020.04.08.20058578.
85. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg
LE. Vitamin D deficiency is common and associated with increased
C-reactive protein in children and young adults with lupus: an
Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy.
Lupus Sci Med. 2014;1(1):e000011.
86. Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG,
Kiefte-de Jong JC, et al. Vitamin D and C-Reactive Protein: A Mendelian
Randomization Study. PLoS One. 2015;10(7):e0131740-e.
87. Li Q, Dai Z, Cao Y, Wang L. Association of C-reactive protein and
vitamin D deficiency with cardiovascular disease: A nationwide
cross-sectional study from National Health and Nutrition Examination
Survey 2007 to 2008. Clinical cardiology. 2019;42(7):663-9.
88. Chandler PD, Scott JB, Drake BF, Ng K, Manson JE, Rifai N, et al.
Impact of vitamin D supplementation on inflammatory markers in African
Americans: results of a four-arm, randomized, placebo-controlled trial.
Cancer prevention research. 2014;7(2):218-25.
89. Mazidi M, Rezaie P, Vatanparast H. Impact of vitamin D
supplementation on C-reactive protein; a systematic review and
meta-analysis of randomized controlled trials. BMC Nutrition.
2018;4(1):1.
90. Xu S, Song J, Zhang Z-H, Fu L, Gao L, Xie D-D, et al. The Vitamin D
status is associated with serum C-reactive protein and adhesion
molecules in patients with renal cell carcinoma. Scientific Reports.
2019;9(1):16719.
91. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg
LE, et al. Vitamin D deficiency is common and associated with increased
C-reactive protein in children and young adults with lupus: an
Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy.
Lupus science & medicine. 2014;1(1):e000011.
92. Luo X, Zhou W, Yan X, Guo T, Wang B, Xia H, et al. Prognostic value
of C-reactive protein in patients with COVID-192020.
93. Wang L. C-reactive protein levels in the early stage of COVID-19.
Medecine et maladies infectieuses. 2020.
94. McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The Effect of
Vitamin D on Renin-Angiotensin-System Activation and Blood Pressure-A
Randomized Control Trial. Journal of hypertension. 2017;35(4):822.
95. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a
negative endocrine regulator of the renin-angiotensin system and blood
pressure. The Journal of steroid biochemistry and molecular biology.
2004;89-90(1-5):387-92.
96. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a
negative endocrine regulator of the renin–angiotensin system and blood
pressure. The Journal of steroid biochemistry and molecular biology.
2004;89:387-92.
97. Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, et al.
Effects of vitamin D supplementation on renin and aldosterone
concentrations in patients with advanced heart failure: the EVITA trial.
International journal of endocrinology. 2018;2018.
98. Li Y. Vitamin D regulation of the renin-angiotensin system. Journal
of cellular biochemistry. 2003;88:327-31.
99. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ.
COVID-19: consider cytokine storm syndromes and immunosuppression. The
Lancet. 2020;395(10229):1033-4.
100. Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T,
et al. 1, 25‐dihydroxyvitamin D3 promotes IL‐10 production in human B
cells. European journal of immunology. 2008;38(8):2210-8.
101. Adams JS, Hewison M. Update in vitamin D. The Journal of clinical
endocrinology and metabolism. 2010;95(2):471-8.
102. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW,
Damoiseaux J, et al. Vitamin D status is positively correlated with
regulatory T cell function in patients with multiple sclerosis. PLoS
One. 2009;4(8):e6635.
103. Lin Z, Li W. The Roles of Vitamin D and Its Analogs in Inflammatory
Diseases. Current topics in medicinal chemistry. 2016;16(11):1242-61.
104. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al.
Vitamin D inhibits monocyte/macrophage proinflammatory cytokine
production by targeting MAPK phosphatase-1. Journal of immunology
(Baltimore, Md : 1950). 2012;188(5):2127-35.
105. Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The
anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in
vivo are due in part to the control of integrin-mediated T lymphocyte
homing. European journal of immunology. 2004;34(4):1068-76.
106. Musselwhite LW, Andrade BB, Ellenberg SS, Tierney A,
Belaunzaran-Zamudio PF, Rupert A, et al. Vitamin D, d-dimer, Interferon
γ, and sCD14 Levels are Independently Associated with Immune
Reconstitution Inflammatory Syndrome: A Prospective, International
Study. EBioMedicine. 2016;4:115-23.
107. Fabre-Mersseman V, Tubiana R, Papagno L, Bayard C, Briceno O,
Fastenackels S, et al. Vitamin D supplementation is associated with
reduced immune activation levels in HIV-1-infected patients on
suppressive antiretroviral therapy. AIDS (London, England).
2014;28(18):2677-82.
108. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D:
modulator of the immune system. Current Opinion in Pharmacology.
2010;10(4):482-96.
109. Yang J, Tian G, Chen D, Zheng P, Yu J, Mao X, et al. Dietary
25-Hydroxyvitamin D(3) Supplementation Alleviates Porcine Epidemic
Diarrhea Virus Infection by Improving Intestinal Structure and Immune
Response in Weaned Pigs. Animals (Basel). 2019;9(9):627.
110. Tian G, Liang X, Chen D, Mao X, Yu J, Zheng P, et al. Vitamin D3
supplementation alleviates rotavirus infection in pigs and IPEC-J2 cells
via regulating the autophagy signaling pathway. The Journal of steroid
biochemistry and molecular biology. 2016;163:157-63.
111. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3
induces autophagy in human monocytes/macrophages via cathelicidin. Cell
host & microbe. 2009;6(3):231-43.
112. Shi YY, Liu TJ, Fu JH, Xu W, Wu LL, Hou AN, et al. Vitamin D/VDR
signaling attenuates lipopolysaccharide‑induced acute lung injury by
maintaining the integrity of the pulmonary epithelial barrier. Molecular
medicine reports. 2016;13(2):1186-94.
113. Esposito S, Lelii M. Vitamin D and respiratory tract infections in
childhood. BMC Infect Dis. 2015;15:487-.
114. Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and
Respiratory Tract Infections: A Systematic Review and Meta-Analysis of
Randomized Controlled Trials. PLoS One. 2013;8(6):e65835-e.
115. Heaney RP. Vitamin D–baseline status and effective dose. The New
England journal of medicine. 2012;367(1):77-8.
116. Martineau AR. Bolus-dose vitamin D and prevention of childhood
pneumonia. Lancet (London, England). 2012;379(9824):1373-5.
117. Hollis BW. Short-term and long-term consequences and concerns
regarding valid assessment of vitamin D deficiency: comparison of recent
food supplementation and clinical guidance reports. Current opinion in
clinical nutrition and metabolic care. 2011;14(6):598-604.
118. Schwalfenberg G. Vitamin D for influenza. Canadian Family
Physician. 2015;61(6):507-.
119. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and
toxicity. Nutrients. 2013;5(9):3605-16.
120. Schwalfenberg G. Vitamin D for influenza. Can Fam Physician.
2015;61(6):507-.
121. Grant WB, Al Anouti F, Moukayed M. Targeted 25-hydroxyvitamin D
concentration measurements and vitamin D3 supplementation can have
important patient and public health benefits. European journal of
clinical nutrition. 2020;74(3):366-76.
122. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano
JL, et al. Evidence that vitamin D supplementation could reduce risk of
influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.
123. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the
effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per
day on biochemical responses and the wellbeing of patients. Nutr J.
2004;3:8.
124. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J,
Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D
supplementation. Osteoporosis international : a journal established as
result of cooperation between the European Foundation for Osteoporosis
and the National Osteoporosis Foundation of the USA. 2010;21(7):1121-32.
125. Sullivan R. Coronavirus: PHE recommends taking vitamin D
supplements as lockdown continues [Newspaper]. Independent; 2020
[Available from:
https://www.independent.co.uk/news/health/coronavirus-lockdown-uk-england-vitamin-d-intake-phe-a9479401.html.
126. Crowe FL, Jolly K, MacArthur C, Manaseki-Holland S, Gittoes N,
Hewison M, et al. Trends in the incidence of testing for vitamin D
deficiency in primary care in the UK: a retrospective analysis of The
Health Improvement Network (THIN), 2005-2015. BMJ Open.
2019;9(6):e028355-e.
127. Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, et al.
National Diet and Nutrition Survey results from years 5 and 6 (combined)
of the Rolling Programme (2012/2013–2013/2014). London: Public Health
England. 2016.